Call Today: 800-889-3898
Submit your Digitek claim details for a free, no obligation case review
Get Started:
The U.S. Food and Drug Administration, (FDA) announced, April 1, a consumer-level recall of certain lots of Caraco brand Digoxin. Digoxin, a generic brand of Digitek ® is designed to treat heart failure and abnormal heart rhythms.
According to the FDA, the recall follows the discovery that some of the pills may differ in size, meaning they may contain too much or too little of the active ingredient, digoxin.
The recalled medication includes the Caraco brand Digoxin, USP, 0.125 mg and Digoxin, USP. 0.25 mg distributed before March 31, 2009 with an expiration date up until September 2011.
Patients treated with the defective digoxin may be at risk of serious injuries. Individuals who overdose on digoxin, the medication designed to treat heart failure, are at risk of digoxin toxicity, which may result in one or more of the following injuries:
On the other hand, patients who take a lower dose of digoxin are at risk of cardiac instability if they are not getting enough medication necessary for treatment.
Caraco Pharmaceutical Laboratories and the FDA notified healthcare professionals of the Digoxin recall, and advised all patients who may have been treated with the defective drug to return the medication to the pharmacy where they purchased the medication. If you suspect that you may have been treated with the wrong-sized Digoxin, it is your best interest to seek medical attention from your doctor immediately.
(Source: FDA)
Have you or a loved one been injured by a defective lot of Digitek ®? If so, you are eligible to recover compensation for your injuries. For more information about the recalled Digoxin and your legal rights, please contact a Digitek Lawyer today.